FDA Review: Alnylam, Cytokinetics, Eli Lilly and More

The FDA had a fairly quiet week, approving drugs, providing clearance, greenlighting clinical trials, and other regulatory activities for Alnylam, Eli Lilly, Cytokinetics, Prometheus, Owlet, and more.

Here’s a look at the agency’s reported activities.